StockData
Harmony Biosciences Holdings, Inc. logo

Harmony Biosciences Holdings, Inc. (HRMY) stock

HRMYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 18/3039% below fair value
$33.01+0.05 (+0.15%)

Close on Nov 17, 2026Market cap $1.92BP/E 10.7Yield –

How the market prices Harmony Biosciences

Each ratio against its own distribution since 2020, from month-end prices and the figures reported at the time

Harmony Biosciences trades at 10.7× its earnings, against a median of 14.2× since 2020 — cheaper than 91% of the months in between.

The shaded bar covers the 5th to 95th percentile of month-end values since 2020, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to earnings since 2020

Median 14.2×, today 10.7×

What Harmony Biosciences keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin75.4%vs 52.8%
Operating margin24.0%vs -42.9%
EBITDA margin24.0%vs -29.3%
Pretax margin25.1%vs -13.0%
Net margin18.9%vs -39.9%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity20.5%vs -53.5%
Return on assets14.6%vs -40.7%
Return on invested capital40.1%vs -32.4%
Return on capital employed20.3%vs -38.7%

How hard the assets work

Revenue per dollar of assets0.77vs 0.39
Inventory turns a year37.87vs 2.68
Revenue per employee$3.28Mvs $405.05K
Profit per employee$618.67Kvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How fast it is growing

Trailing twelve months against a year earlier, and the compound annual rate over three and five fiscal years

Last 12 months3-year, a year5-year, a yearIndustry median

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $513.83M. That is 36.5% of the $1.41B it would cost to buy the business outright.

Total debt$153.96M
Cash and short-term investments$667.79M
EBITDA, trailing twelve months$230.65M

Leverage and liquidity

Debt to equity0.15vs 0.50
Debt to EBITDA0.67vs 3.42
Net debt to EBITDA-2.23vs 2.33
Current ratio3.48vs 3.28
Quick ratio3.33vs 2.37

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

5.12
DistressGrey zoneSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

5 of 9 tests passed

Price against two rules of thumb

Graham's number and Lynch's fair value, both derived from current earnings.

Price $33.01Graham $34.54

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield9.43%vs -22.8%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 17, 2026

$25.9052-week low52-week high$43.49
$33.01200-day20-day50-day

The close sits 40% of the way up the 52-week range, 24.1% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

34
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

HRMYS&P 500
PeriodHRMYS&P 500DifferenceHRMY per yearS&P 500 per year
1 month-13.0%-4.0%−9.0 pts
3 months-13.5%-5.0%−8.5 pts
Year to date-11.8%+8.2%−20.0 pts
1 year-2.9%+11.2%−14.1 pts
3 years+22.4%+68.5%−46.1 pts+7.0%+19.0%
5 years-17.7%+67.3%−85.0 pts-3.8%+10.8%

How much it moves

Volatility, 1 year40.6%vs 80.5%
Volume against its 90-day average0.63vs 0.86

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

7M HRMY shares were sold short on Oct 30, 2026, up 23.1% from the previous report, or 13.01% of the shares available to trade. At recent volumes it would take 5.6 days to buy them back. Over the last 20 sessions, 72.4% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float13.0%vs 8.89%
Short interest as a share of all shares11.4%vs 6.30%
Days of volume to buy it back5.63vs 5.13

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20266,664,944+23.1%1,183,5525.6
Oct 15, 20265,413,347-2.2%876,1056.2
Sep 30, 20265,532,301+19.5%1,108,1145.0
Sep 15, 20264,628,716-10.4%1,067,7134.3
Aug 31, 20265,164,996+24.9%566,6509.1
Aug 14, 20264,136,259-8.0%866,8054.8
Jul 31, 20264,496,943-12.1%889,7015.0
Jul 15, 20265,114,969+10.9%754,0936.8
Jun 30, 20264,611,754-0.7%809,5665.7
Jun 15, 20264,645,233-21.8%894,7515.2
May 29, 20265,940,252-10.2%689,1108.6
May 15, 20266,618,020-4.1%805,9118.2

Every measure, in full

91 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Feb 23, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 17, 2026

Valuation ratiosIndustry

Market Cap
$1.92B
$254.69M
Enterprise Value
$1.41B
$130.88M
PE Ratio
10.68
23.02
PS Ratio
2.00
3.66
PB Ratio
1.92
1.99
P/TBV Ratio
2.09
2.23
P/OCF Ratio
5.41
13.24

Enterprise valuationIndustry

EV / Sales
1.47
2.38
EV / EBITDA
6.11
16.00
EV / EBIT
6.11
18.86

Share statisticsIndustry

Shares Change (YoY)
0.40%
11.0%
Shares Change (QoQ)
0.44%
0.57%
Float
51M
49M
Shares Held by Insiders
12.1%
11.3%
Shares Held by Institutions
93.0%
56.3%

Short sellingIndustry

Short Interest
7M
–
Short Interest Change
23.1%
-0.80%
Short % of Float
13.0%
8.89%
Short % of Shares Outstanding
11.4%
6.30%
Days to Cover
5.63
5.13

Stock price statisticsIndustry

52-Week High
$43.49
–
52-Week Low
$25.90
–
20-Day Moving Average
$35.56
–
50-Day Moving Average
$38.28
–
200-Day Moving Average
$34.53
–
Average True Range (14)
$1.52
–
Price Change (1 Week)
-1.61%
-7.83%
Price Change (1 Month)
-12.1%
-6.48%
Price Change (3 Months)
-17.3%
-26.6%
Price Change (6 Months)
8.44%
-22.2%
Price Change (YTD)
-11.8%
-25.6%
Price Change (1 Year)
-3.00%
-23.8%
Price Change (3 Years)
22.4%
-32.9%
Price Change (5 Years)
-15.7%
-77.3%
Average Volume (10 Days)
1M
–
Average Volume (20 Days)
1M
–
Average Volume (90 Days)
968,899
–
Relative Volume
0.63
0.86
Relative Strength Index (14)
33.9
40.3
Volatility (1 Year)
40.6%
80.5%

MarginsIndustry

Gross Margin
75.4%
52.8%
Operating Margin
24.0%
-42.9%
Pretax Margin
25.1%
-13.0%
Profit Margin
18.9%
-39.9%
EBITDA Margin
24.0%
-29.3%

Returns on capitalIndustry

Return on Equity (ROE)
20.5%
-53.5%
Return on Assets (ROA)
14.6%
-40.7%
Return on Invested Capital (ROIC)
40.1%
-32.4%
Return on Capital Employed (ROCE)
20.3%
-38.7%

Financial positionIndustry

Current Ratio
3.48
3.28
Quick Ratio
3.33
2.37
Debt / Equity
0.15
0.50
Debt / EBITDA
0.67
3.42
Net Debt / EBITDA
-2.23
2.33
Interest Coverage
17.12
-6.20

GrowthIndustry

Revenue Growth (YoY)
24.3%
5.68%
Net Income Growth (YoY)
0.20%
-31.1%
EPS Growth (YoY)
-0.32%
-25.8%
Revenue Growth (3Y CAGR)
25.6%
2.25%
Revenue Growth (5Y CAGR)
40.3%
6.41%
EPS Growth (3Y CAGR)
-3.01%
-0.17%

EfficiencyIndustry

Asset Turnover
0.77
0.39
Inventory Turnover
37.87
2.68
Revenue Per Employee
$3.28M
$405.05K
Profits Per Employee
$618.67K
-$704.12K
Employee Count
293
75

Income statement (TTM)Industry

Revenue
$959.90M
$58.79M
Gross Profit
$723.99M
$103.58M
Operating Income
$230.65M
-$21.49M
Pretax Income
$241.20M
-$14.83M
Net Income
$181.27M
-$22.47M
EBITDA
$230.65M
-$17.14M
EPS (Diluted)
$3.09
-$0.83

Balance sheetIndustry

Total Debt
$153.96M
$114.91M
Net Cash (Debt)
$513.83M
$15.31M
Net Cash Per Share
$8.82
$0.72
Equity (Book Value)
$999.24M
$49.40M
Book Value Per Share
$17.16
$1.45
Tangible Book Value
$921.75M
$23.58M
Working Capital
$580.26M
$74.34M

Cash flow (TTM)Industry

Operating Cash Flow
$355.08M
-$12.17M

Dividends and yieldsIndustry

Earnings Yield
9.43%
-22.8%

Taxes and interestIndustry

Interest Expense
$13.47M
$3.07M
Income Tax
$59.93M
$77.43K
Effective Tax Rate
24.8%
20.7%

Scores and fair valueIndustry

Graham Number
$34.54
$19.07
Graham Upside
4.63%
-47.6%
Altman Z-Score
5.12
0.12
Piotroski F-Score
5
4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?